- COVID-19 Vaccination Screening & Consent Form under EUA (English)
- COVID-19 Vaccination Consent under Emergency Use Authorization (Spanish)
- Janssen resources
- Pfizer resources
- Moderna resources
- Vaccine Shipment Tracker
- Product Information Guide for COVID-19 Vaccines and Associated Products
- Interim Clinical Considerations
- FAQs for Healthcare Professionals
Publicize Vaccine Clinics
Vaccinations for Minors
Printable Job Aids
- Vaccine Administration: Intramuscular (IM) Injection Infants 11 months of age and younger
- Vaccine Administration: Intramuscular (IM) Injection Children 1 through 2 years of age
- Vaccine Administration: Intramuscular (IM) Injection Children 3 through 6 years of age
- Vaccine Administration: Intramuscular (IM) Injection Children 7 through 18 years of age
- Vaccine Administration: Needle Gauge and Length
- Vaccinations of Non-Missouri Residents
- Syringe/Dose Preparation for COVID Vaccine Administration
- Administration Errors and Deviations
- Vaccine Quick Reference Guide
- What to Expect After Getting a COVID-19 Vaccine (factsheet)
- Increasing COVID-19 Vaccine Uptake among Members of Racial and Ethnic Minority Co
- Inventory Adjustments and Wastage
- Matching Prime and Booster Doses
- How to Avoid Wastage at Vaccination Events
- The Effect of Ionizing Radiation on Cyclic Olefenic Polymer Color
- CDC – Homebound Guidance, Training and Clinical Resources on management of vaccines and vaccination for persons vaccinated at home
- V-Safe Patient Health Check-in App
- CDC – COVID-19 Vaccination Clinical Resources
- CDC - Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States
- CDC MMWR Advisories
- Janssen/Johnson & Johnson education webinars
- CDC Resource Library
- CDC Vaccines – Training & Education
Regional Implementation Teams
Registered users can now access COVID-19 vaccine lot numbers and expiration dates provided to CDC by the vaccine manufacturer from downloadable tabular files for use in vaccine administration, inventory management, and jurisdictional immunization information systems. These files will contain all lots for COVID-19 vaccines made available under Emergency Use Authorization (EUA) for distribution in the United States. The files include the manufacturer, the National Drug Codes (NDCs) for Unit of Sale (boxes/cartons) and Unit of Use (vials) for each lot number, and the manufacture date and expiration date.
Files will be updated on a daily basis Monday through Friday as new lots are released by each manufacturer, or as updates are made to the lot expiration dates. Please note that as manufacturers confirm their product stability data, some expiration dates may be updated.
Access to lot number and expiration date information is controlled for security reasons. To request access to the lot number and expiration date data files, complete the registration page, acknowledge the terms and conditions for access and use of the data, and create a password. We will evaluate your request and send the registration approval decision within 48 hours to the email address you provided during registration. If approved, the email will include a link and instructions for accessing the files.
Enrolled providers can submit an online vaccine order request weekly. The deadline to submit requests each week is 5 p.m. Wednesday. Orders approved ship the following week. Providers will receive an automated response that the order request has been received. An email confirmation will be sent if an order is placed on the provider's behalf. Please do not send multiple order requests within the same week.
It is acceptable and encouraged to submit a new order request for each week that your facility desires vaccines. Order requests that are not fulfilled will not be held over week to week. The State’s ability to fill vaccine order requests is contingent on vaccine supply. The submission of an order request does not guarantee an order will be filled.
Submit a redistribution request form. Please allow 24 business hours for redistribution requests to be processed and approved. All requests must be approved prior to the redistribution of COVID-19 vaccines.
In order to request to transfer vaccine from your location to another, a redistribution agreement must first be in place.
When transferring vaccine, make sure you are also transferring the ancillary kits. Only unopened vaccines should be transferred. No open vials or partial doses in syringes should be transferred. Transferring of inventory must be documented in ShowMeVax in the On Hand Inventory Module by clicking on Action, then Transfer.
Further questions should be directed to email@example.com.
|Order Placed||Order Received|
|Order Placed||Order Received|
Individuals who are exposed to COVID-19 do not need to quarantine if they are fully vaccinated (i.e., ≥2 weeks following receipt of the second dose in a 2-dose series, or ≥2 weeks following receipt of one dose of a single-dose vaccine).
While we have many various groups that wish to assist by serving as vaccinators, ensuring only appropriate access to HIPAA-protected information is of paramount importance. While there may be a few limited circumstances in which these arrangements with external partners may be the appropriate course of action, generally, DHSS will be working with Regional Implementation Teams, LPHAs, health care providers and pharmacies for the purpose of registering as vaccinators. Generally, these groups will be the only ones that may have access to or register as ShowMeVax providers.
Yes, with the following conditions:
- Storing site must be an enrolled COVID-19 Vaccine Provider
- Storing site must be less than 10 miles away from the site of the original provider. This statement is only referring to storage and is not intended to limit redistribution efforts with mileage limits.
- Storing site must provide daily temperature logs to original provider
- Provider must use vaccine within 10 days of receipt
- All inventory must be entered into SMV and reported to Vaccine Finder daily
- Vaccine administration must be reported within 24 hours of dose administration
- All other requirements listed in the COVID-19 Provider Agreement must be honored
The COVID-19 vaccination provider agreement states that the provider must dispose of wasted COVID-19 vaccines according to the state’s procedures. Sites should dispose of COVID-19 vaccine waste in accordance with local regulations and processes they are currently using to dispose of regulated medical waste. In addition, COVID-19 vaccine program requirements include providers reporting wastage (e.g., unused, spoiled, or expired) information according to the ShowMeVax system.
To report wastage, such as drawn but not administered, diluted but not administered, etc, go to the location’s On Hand Inventory and find the lot number of the vaccine. Click on Action, then Adjustment. In the Reason box, please select one of the VtrkS options for reasons that best describes the situation. Enter the number of doses you are wasting and enter any comments necessary. Then click on the green Create button.
To report a return, such as expired or spoiled due to temperature excursion, go to Inventory, then Vaccines, then Vaccine Return. Click on the green ‘Add New Vaccine Return’ button at the top of the screen and then select the location where the vaccine is located, then select Next. You will then be able to fill out the return request based on the vaccine in your location’s inventory. Once completed, click on the green “Create” button. Information will be sent to our Support Team for processing. You will receive additional information via email as well as a return shipping label to return the vaccine to the manufacturer.
Please contact the support team at firstname.lastname@example.org should you have questions on how to process wastage and/or return.
Vaccine Finder - Federal requirement-Daily Reporting Required
What is it? A CDC requirement mandatory for all COVID vaccinators today
- What is required? Update vaccine inventory in VaccineFinder each day no later than midnight local time (federal requirement)
How will I be notified? After you enroll as a COVID provider in ShowMeVax (SMV) an email to create an account to complete the registration will be sent to the provider organization's email address submitted in the provider enrollment form. The email will be from email@example.com.
- Do you know who is listed for your organization?
- Please also check spam/junk folders for this email.
- This is a personalized link that will expire in 7 days.
What if I haven't been notified? If you do not receive an email and have received vaccine, please email firstname.lastname@example.org for registration assistance. You should send an email here for assistance if your link has expired.
For technical assistance with account log-in problems, password resets, file upload errors, etc. please email email@example.com.
ShowMeVax (SMV) - State requirement-Weekly/Monthly Reporting Required
What is it? State system that helps us monitor and help redistribute vaccines to those who need them the most. We can only do this if the inventories we use to plan are accurate. That's why we need your help!
Where can I find out more? Provider resources are available in the Report Module in the Missouri Forms and Document section. You can also reach out to firstname.lastname@example.org
What do I need to do? Upon receipt of vaccine (direct ship or redistribution) log into SMV and add the inventory to your on-hand inventory. Log into SMV, go to Inventory>Vaccines>On Hand. Look for a blue link at top of page regarding shipments/transfers. Click on blue link and verify if shipment has been received. Click on Receive and the doses will populate over to your on hand inventory. If you do not see a blue link, you will need to add manually. Directions for this process are located in the 'Reports' section of SMV, under 'Missouri Forms and Documents' --> 'Adding Vaccine Inventory'.
What if I received vaccine through a redistribution? Redistributed vaccine must be documented in SMV. Here's how:
- The sending facility will create an 'Adjustment' in the On Hand Inventory as a 'Transfer' to the receiving facility.
- The receiving facility will accept the transfer by clicking on the blue link located at the top of the page in the On Hand Inventory module.
How do I reconcile/report my inventory on a weekly basis in SMV? You can reconcile/report in two ways: DO NOT ENTER ‘ADJUSTMENTS’ (SUBTRACT DOSES) FROM YOUR ON HAND INVENTORY. THIS IS NOT THE PROPER WAY TO RECONCILE INVENTORY.
- Manual entry - Please refer to the 'User Guide' in the 'Report module'
- Auto-decrementing for HL7 Interface Users - Please refer to the 'User Guide' in the 'Report' module
Inventory reporting is required to ensure you are eligible to receive additional orders/shipments of vaccine. Failure to report could cause failure to receive vaccine.
Vaccinators are required to report all vaccinations in ShowMeVax and VaccineFinder within 24 hours (with a 72-hour grace period to start). This information is critical for us to monitor supply and vaccination levels around the state.
There are several options available to providers for transmitting the required data elements of the COVID-19 vaccination to ShowMeVax:
- HL7 Interface
- HL7 Batch Upload
- Manual Entry through the ShowMeVax portal
Please know that if your organization is not documenting priority population administration in your electronic health record or utilizing a hub, an HL7 batch upload or manual entry are your options for populating ShowMeVax. If your organization is not utilizing an electronic health record or hub, manual entry is your only option for populating ShowMeVax.
Please communicate your strategy for transmitting vaccinations to ShowMeVax to the Reporting Team at email@example.com. Once registered, the Reporting Team will provide the appropriate implementation guides and how-to procedures. It is important to test your documentation option with the Reporting Team prior to your first vaccination. Thank you for your diligence in reporting this information.
Please ensure staff are verifying patient and dose information before submitting the dose documentation. (For example, ensure the correct administration date is listed in the patient record/HL7 message).
For more information about VaccineFinder enrollment, please visit their website.
- Providers with an electronic medical record system actively submit immunizations to ShowMeVax via an HL7 message. Do not manually enter into ShowMeVax;
- Providers with an electronic medical record system and not currently submitting to ShowMeVax must manually enter immunizations into ShowMeVax. There are two options:
- IZ Quick Add method –Does not deduct from current vaccine inventory; Inventory will not be updated, until a reconciliation is completed by manually reporting total doses administered and total doses currently on hand;
- Enter immunizations using the Patient Module. Search for patient. Click on arrow beside “Demographics” and select “Immunizations”. Click on ‘Select Action” arrow and click on “Add Administered”. You will be able to add the vaccines administered and the ability to select the vaccine information from your on hand inventory. This will then deduct the dose from the on hand inventory.
A COVID Administrator user has been added as a drop down option for vaccine administrator. Please use this option when temporary staff or outside resources are being utilized to assist with vaccination efforts. You will still need to have the actual name of the person and their signature on all paper and electronic consents for vaccination.
Instruction guides are also available within ShowMeVax in the Report Module under Missouri Forms and Documents.
If an error occurs during the administration of a vaccine dose, vaccinators should:
- Inform the recipient of the vaccine administration error.
- Consult with the state immunization program and/or Immunization Information System (IIS) to determine how the dose should be entered into the IIS, both as an administered dose and to account for inventory.
- Report the error to the Vaccine Adverse Event Reporting System (VAERS), unless otherwise indicated in the table. Providers are required to report all COVID-19 vaccine administration errors—even those not associated with an adverse event — to the VAERS. To file an electronic report, please see the VAERS website.
- Determine how the error occurred and implement strategies to prevent it from happening again. A discussion on strategies to prevent errors can be found in the Vaccine Administration chapter of the Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book). Additional resources can be found on CDC’s vaccine administration web page, including a job aid for preventing errors.
For a list of errors and revaccination Guidance, click here
Vaccinators must document temperatures for each storage unit that maintains COVID-19 vaccine. However, providers are not required to report or upload their temperatures in ShowMeVax. A paper temperature log can be maintained on site and available for review upon request. A temperature log template is available in ShowMeVax in the Report module under Missouri Forms and Documents. VFC Providers must still report their temperatures in ShowMeVax.
After the Pfizer vaccine shipment arrives you will receive an email from Controlant©. If the shipper will not be used to store vaccine you will need to respond to the email to opt of this program.
If your organization has a firewall that blocks access to the activation link you will need to follow the steps below:
- Open Google Chrome (do not use another browser)
- Go to: https://usg.bi.controlant.info/account/login
- Use the username and password provided in the email
- You will be directed to the Controlant dashboard and asked to reset your password
Providers are required to report adverse effects as quickly as possible via VAERS.
The CDC has issued Interim Considerations for Preparing for the Potential Management of Anaphylaxis at COVID-19 Vaccination Sites. Appropriate medical treatment for severe allergic reactions must be immediately available in the event that an acute anaphylactic reaction occurs following administration of Pfizer-BioNTech COVID-19 vaccine.
Vaccination providers should also be reminded to review, implement, and consult CDC’s Interim Clinical Considerations for Use of Pfizer-BioNTech COVID-19 vaccine. All ACIP recommendations related to COVID-19 vaccine can be found at ACIP COVID-19 Vaccine Recommendations.
Providers may report any vaccine adverse event that occurs. Reports are reviewed daily and weekly by CDC to determine if follow-up is needed.
All organizations and providers participating in the CDC COVID-19 Vaccination Program:
- must administer COVID-19 Vaccine at no out-of-pocket cost to the recipient
- may not deny anyone vaccination based on the vaccine recipient’s coverage status or network status
- may not charge an office visit or other fee if COVID-19 vaccination is the sole medical service provided
- may not require additional medical services to receive COVID-19 vaccination
- may seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees for the vaccine recipient, such as:
- vaccine recipient’s private insurance company
- Medicare or Medicaid reimbursement
- HRSA COVID-19 Uninsured Program for non-insured vaccine recipients
- may not seek any reimbursement, including through balance billing, from the vaccine recipient
For additional information on filing claims for reimbursement of COVID-19 vaccine administration fees, go to:
Yes, those who have or have a history of thrombocytopenia, who have or have a history of a low platelet count, prior surgery (cardiac, orthopedic, trauma), cardiovascular disease, oral contraceptive use or hereditary thrombophilia. If you experience any of the following symptoms seek medical attention right away: Shortness of breath, chest pain, leg pain or swelling, backache, persistent abdominal pain, severe and persistent headaches, visual changes or easy bruising or tiny blood spots under the skin beyond the site of the injection.
Treatment is different from what might typically be administered; while usually heparin is used to treat blood clots, it is dangerous to give heparin if someone has a blood clot from the Johnson & Johnson vaccine.
COVID-19 vaccines and other vaccines may now be administered without regard to timing. This includes simultaneous administration of COVID-19 vaccine and other vaccines on the same day, as well as co-administration within 14 days. It is unknown whether reactogenicity of COVID-19 vaccine is increased with co-administration, including with other vaccines known to be more reactogenic, such as adjuvanted vaccines or live vaccines. When deciding whether to co-administer another vaccine(s) with COVID-19 vaccine, providers should consider whether the patient is behind or at risk of becoming behind on recommended vaccines, their risk of vaccine-preventable disease (e.g., during an outbreak or occupational exposures), and the reactogenicity profile of the vaccines.
If multiple vaccines are administered at a single visit, administer each injection in a different injection site. For adolescents and adults, the deltoid muscle can be used for more than one intramuscular injection.
Best practices for multiple injections include:
- Label each syringe with the name and the dosage (amount) of the vaccine, lot number, the initials of the preparer, and the exact beyond-use time, if applicable.
- Separate injection sites by 1 inch or more, if possible.
- Administer the COVID-19 vaccines and vaccines that may be more likely to cause a local reaction (e.g., tetanus-toxoid-containing and adjuvanted vaccines) in different limbs, if possible.
Minimum doses of 100
100 mcg/0.5 mL, multi-dose vials, 5 doses
Minimum doses of 140
100 mcg/0.5 mL, multi-dose vials, 14 doses
Minimum doses of 1,170
30 mcg/0.3mL, multi-dose vials, 6 doses